Disclaimer: This image is entirely AI-generated and is a product of artificial intelligence. Any resemblance to actual persons, whether living or deceased, is purely coincidental and unintentional.
Uploaded 1 week ago
Duration: 0h 4m 9s
Piramal Pharma looks to return on growth path
Piramal Pharma anticipates a significant turnaround in financial year 2026-27 (FY27), projecting early-to-mid teens revenue expansion and a sharp improvement in profitability, driven by improved business momentum, new product acquisitions, and structural tailwinds.
Uploaded by: Rediff Video Desk on Fri, 08 May 2026 09:00:00 +0530
Views: 28
Tags: Piramal Pharma looks to return on growth path
© 2026